arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

HERBALIFE LTD.

HLF
$12.34 ▲ +0.84 (+7.30%) at close
Healthcare ·Wholesale-Drugs, Proprietaries & Druggists' Sundries ·USWholesale-Drugs, Proprietaries & Druggists' Sundries
71 Visible periods
33 Metrics
Peer-ranked Benchmarks
Price Chart
50
Health
Weak
Neutral
auto_awesome

Analytical Summary

HERBALIFE LTD. shows mixed fundamentals. On the positive side, Debt to Equity remains strong. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $1.3B
Dividend Yield
Revenue Growth 7.8%
Op. Margin 10.5%
ROIC 6.0%
FCF / Share $0.99
Trailing P/E 20.6x
Price / Book
FCF Yield 8.0%
Debt / Equity -4.51
info Valuation on last close. End-of-day price, Aug 7, 2026.

71-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.32B
↑ +7.8%
Net Income Profit after all expenses
$61.90M
↑ +22.8%
Operating Margin Operating profit as % of sales
10.5%
↑ +35.1% 55th
FCF / Share Free cash flow per share
$0.99
↓ -13.2%
Long-Term Debt Long-term obligations
$1.99B
— -0.1%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
49
Returns
18
Financial Health
80
Cash Quality
70

Dividend History

Dividend / share · sourced from SEC filings
$0.15 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 19 years · 71 quarters